Barbara Furie, PhD, and Bruce Furie, MD, to Present 2015 ASH E. Donnall Thomas Lecture

Get Permission

Barbara Furie, PhD and Bruce Furie, MD

The American Society of Hematology (ASH) will honor Barbara Furie, PhD, of Harvard Medical School, and Bruce Furie, MD, of Beth Israel Deaconess Medical Center and Harvard Medical School, with the 2015 E. Donnall Thomas Lecture for their groundbreaking research in hemostasis and thrombosis over the past 40 years. The Furies are international leaders in hemostasis and thrombosis, and their outstanding research program has made landmark contributions to the understanding of the structure, biochemistry, and function of coagulation and platelet proteins. This award, named after the late Nobel Prize Laureate and Past President of ASH E. Donnall Thomas, MD, recognizes pioneering research achievements in hematology, which have represented a paradigm shift or significant discovery in the field.

The Furies will present their lecture, “Thiol Isomerases as Potential Regulators Controlling the Initiation of Thrombus Formation,” on Monday, December 7, at the 57th ASH Annual Meeting and Exposition in Orlando, Florida. 

In 1975, the Furies founded the Center for Hemostasis and Thrombosis Research at Tufts University School of Medicine and New England Medical Center, to conduct interdisciplinary research in the areas of blood coagulation and platelet and vascular biology. During its 40 years in operation, the Furie Lab, which moved to Harvard Medical School and the Beth Israel Deaconess Medical Center in 1997 and became the Division of Hemostasis and Thrombosis in 2000, has hosted more than 100 young investigators for research training.

Dr. Barbara Furie is currently Professor Emeritus at Harvard Medical School, where she previously served as Co-Chief of the Division of Hemostasis and Thrombosis and Professor of Medicine. She earned her PhD in chemistry from the University of Pennsylvania.

Dr. Bruce Furie is currently Chief of Hemostasis-Thrombosis at Beth Israel Deaconess Medical Center, where he also directs the Blood Coagulation and Vascular Biology Training Program. He also serves as Professor of Medicine at Harvard Medical School. ■





By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.